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In Brief
SH2 domains mediate complex protein-
protein interactions during diverse cell-
signaling pathways. Park et al. discover
that lipids directly bind SH2 domains and
modulate SH2 domain-mediated protein-
protein interactions. PI45P2 and PIP3
spatiotemporally coordinate T cell-
signaling activities through their
interaction with SH2 domains of signaling
proteins, including ZAP70.
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The Src-homology 2 (SH2) domain is a protein inter-
action domain that directs myriad phosphotyrosine
(pY)-signaling pathways. Genome-wide screening
of human SH2 domains reveals that 90% of SH2
domains bind plasma membrane lipids and many
have high phosphoinositide specificity. They bind
lipids using surface cationic patches separate
from pY-binding pockets, thus binding lipids and
the pY motif independently. The patches form
grooves for specific lipid headgroup recognition or
flat surfaces for non-specific membrane binding
and both types of interaction are important for
cellular function and regulation of SH2 domain-
containing proteins. Cellular studies with ZAP70
showed that multiple lipids bind its C-terminal SH2
domain in a spatiotemporally specific manner and
thereby exert exquisite spatiotemporal control
over its protein binding and signaling activities in
T cells. Collectively, this study reveals how lipids
control SH2 domain-mediated cellular protein-
protein interaction networks and suggest a new
strategy for therapeutic modulation of pY-signaling
pathways.
INTRODUCTION
The Src-homology 2 (SH2) domain is a prototypal modular pro-
tein interaction domain (PID) and has long served as an excellent
model system for studying protein-protein interactions (Pawson,
2004). Since its discovery as the first PID in v-fps/fes oncogene in
Fujinami sarcoma virus (Sadowski et al., 1986), the SH2 domain
has been identified in diverse cellular proteins in a wide variety ofeukaryotes, but primarily in metazoans. The human genome
encodes 121 SH2 domains in 111 different proteins, including
kinases, adaptors, phosphatases, and other signaling mole-
cules (Pawson, 2004). As a major reader of phosphotyrosine
(pY)-signaling information, SH2 domain-containing proteins
play crucial roles in linking various protein tyrosine kinases to
downstream molecules, thereby controlling the specificity of
pY signaling (Lim and Pawson, 2010).
Structural analysis of a wide range of SH2 domains and their
complexes with pY peptides has revealed that SH2 domains
have a common architecture made of two a helices flanking
antiparallel b strands (Pawson, 2004; Waksman et al., 1993).
They specifically recognize pY and a few residues immediately
C-terminal to pY using a pY-binding pocket and a secondary
binding site, respectively (Pawson, 2004). However, quantitative
analysis has shown that SH2 domains bind pY-containing
peptides with variable affinity and a significant degree of promis-
cuity (Ladbury and Arold, 2000; Machida and Mayer, 2005).
Exquisite protein interaction specificity required for high-fidelity
pY signaling thus has to be augmented by other mechanisms,
such as protein compartmentalization (Good et al., 2011; Scott
and Pawson, 2009), signaling complex formation (Bray, 1998;
Cho, 2006), or pY-independent secondary protein interactions
(Bae et al., 2009).
Recent studies have suggested that membrane lipids play a
role in modulating cellular protein-protein interactions mediated
by another PID, PDZ (PSD95, Dlg1, ZO-1) domain (Chen et al.,
2012; Feng and Zhang, 2009; Sheng et al., 2012, 2014; Wu
et al., 2007; Zimmermann et al., 2002). It also was reported
that some SH2 domains could bind lipids, which either inhibited
(Rameh et al., 1995) or promoted (Bae et al., 1998) the activity of
their host proteins; however, the mechanisms, the physiological
significance, and the universality of these findings remain
controversial (Surdo et al., 1999). In this study, we thoroughly
and systematically investigated the potential roles of lipids in
regulating SH2 domain-mediated protein-protein interactions
and cellular signaling activities.Molecular Cell 62, 7–20, April 7, 2016 ª2016 Elsevier Inc. 7
RESULTS
Membrane-Binding Analysis of Human SH2 Domains
We quantitatively measured the lipid-binding affinity and speci-
ficity of human SH2 domains on a genomic scale by surface
plasmon resonance (SPR) analysis. Since many of these SH2
domains were not stably expressed in Escherichia coli, we ex-
pressed them as EGFP-fusion proteins, which significantly
improved the protein expression yield for most SH2 domains.
Our control experiments showed that a properly placed EGFP
tag did not affect the membrane-binding properties of SH2 do-
mains (see Table S1). Of 121 human SH2 domains, we were
able to rigorously characterize 76 domains that can be prepared
stably and in amounts sufficient for biophysical studies. A major-
ity of SH2 domain proteins interact with pY-containing proteins
that are either associated with or act near the cytofacial leaflet
of the plasma membrane (PM). We thus used for our measure-
ments the vesicles whose lipid composition recapitulates that
of the cytofacial PM (referred to as PM-mimetic vesicles here-
after) (Cho and Stahelin, 2005).
Our initial strategy was to screen for SH2 domains that yielded
a high response in rapid SPR screening with the PM-mimetic
vesicles, but, since a majority of them gave high enough SPR
signals, we determined the Kd values for all available SH2 do-
mains. The Kd values of 76 human (and one yeast) SH2 domains
(Table 1) revealed that 74% of them have submicromolar affinity
for the PM-mimetic vesicles. This level of membrane affinity is
comparable to that of other lipid-binding proteins (Cho and Sta-
helin, 2005). Also, 13 additional SH2 domains had Kd values in
the range of 1–5 mM. Only eight SH2 domains (z10%) exhibited
no detectable binding to the PM-mimetic vesicles.
To assess the specific nature of SH2 domain-lipid binding,
we randomly selected 18 SH2 domains with high PM affinity
and measured their lipid headgroup selectivity. In particular,
we determined selectivity for phosphoinositides (PtdInsP), which
play key roles in cell signaling (Di Paolo and De Camilli, 2006).
Among tested SH2 domains, 12 of them exhibited PtdInsP selec-
tivity that is comparable to that of the Akt1 pleckstrin homology
(PH) domain, a canonical PtdInsP-binding domain (Figure S1;
Table 1). Many phosphatidylinositol-3,4,5-trisphosphate (PIP3)-
binding PH domains, including Akt1-PH, bind phosphatidylinosi-
tol-3,4-bisphosphate (PI34P2) as well as PIP3 (Figure S1; Manna
et al., 2007). Interestingly, most of PtdInsP-selective SH2 do-
mains prefer PIP3 and phosphatidylinositol-4,5-bisphosphate
(PI45P2) to other PtdInsPs. Their selectivity for PI45P2 over
isoelectric PI34P2 and phosphatidylinositol-3,5-bisphosphate
(PI35P2) shows that their PtdInsP binding is driven not by non-
specific electrostatic binding but by specific PtdInsP headgroup
recognition. This notion is further supported by the finding that
some SH2 domains, including BMX-SH2 and YES1-SH2, prefer
PI45P2 to more anionic PIP3 (Figure S1). Overall, favorable bind-
ing of most SH2 domains to PI45P2 might be important for their
PM binding under physiological condition given that PI45P2 is
the most abundant PtdInsP in the PM of mammalian cells
(McLaughlin et al., 2002). Six SH2 domains did not show clear
PtdInsP selectivity, i.e., they did not clearly distinguish among
PI45P2, PI34P2, and PI35P2 (e.g., see Btk-SH2 and PTK6-SH2
in Figure S1). Even for these SH2 domains, however, the addi-8 Molecular Cell 62, 7–20, April 7, 2016tion of PIP3 and PI45P2 to vesicles significantly enhanced their
membrane affinity, suggesting that PIP3 and PI45P2 also might
facilitate their PM binding under physiological conditions.
To prove that PIP3 and PI45P2 play an important role in PM
localization of SH2 domains, we measured the PM localization
of PIP3-selective (ZAP70-cSH2: the C-terminal unit of the
tandem SH2 domains), PI45P2-selective (BMX-SH2 and YES1-
SH2), and non-selective (PTK6-SH2) SH2 domains in response
to rapamycin-triggered PI45P2 depletion (Inoue et al., 2005;
Varnai et al., 2006) and PIP3 enrichment (Inoue and Meyer,
2008) in the PM. Before rapamycin treatment, all these SH2
domains showedPM localization, albeit to different degrees (Fig-
ure 1). When PI45P2 was depleted, PI45P2-selective BMX-SH2
(Figure 1A) and YES1-SH2 domains (Figure 1B) were rapidly
(<1 min) removed from the PM, whereas PIP3-selective ZAP70-
cSH2 (Figure 1D) showed only a minor degree of PM displace-
ment. In contrast, PIP3 enrichment significantly increased the
PM localization of ZAP70-cSH2 (Figure 1D), while showing little
effect on that of BMX-SH2 (Figure 1A) andYES1-SH2 (Figure 1B).
These results support the physiological significance of PIP3 and
PI45P2 selectivity of these SH2 domains. Lastly, PM recruitment
of non-selective PTK6-SH2 also was affected by both PI45P2
depletion and PIP3 enrichment (Figure 1C), albeit to lesser de-
grees, supporting the notion that both PI45P2 and PIP3 also
facilitate its PM recruitment under physiological conditions.
Identification of Lipid-Binding Sites of SH2 Domains
Electrostatic potential computation of human SH2 domains
shows that all have highly cationic pY-binding pockets (Fig-
ure 2). Interestingly, many of them also contain alternate cationic
patches (ACPs) (Figure 2). In general, these ACPs are not as
electropositive as pY pockets, but most of them contain neigh-
boring hydrophobic and aromatic residues, which is reminiscent
of lipid-binding sites of membrane-binding proteins (Cho and
Stahelin, 2005). We thus suspected that either or both of these
cationic sites might serve as a binding site for anionic lipids
including PtdInsPs. Previous studies suggested that the pY
pocket might be the main site for lipid binding (Hong et al.,
2009; Rameh et al., 1995; Tokonzaba et al., 2006). We found,
however, that mutation of single or multiple cationic residues in
the pY pockets of five randomly selected SH2 domains did
not cause significant decreases in vesicle binding (Figure S2A).
In contrast, mutations of ACP residues of these SH2 domains
plus three additional SH2 domains reduced vesicle affinity to a
much greater extent (Figure S2B). Furthermore, non-lipid-bind-
ing SH2 domains, such as Syk N-terminal SH2 domain (nSH2)
and SHD-SH2, lack ACPs while possessing cationic pY pockets
(Figure 2). These results suggest that not the pY pockets but
the ACPs serve as the primary lipid-binding sites for most SH2
domains. This notion is further supported by the subcellular
localization patterns of SH2 domain mutants in HeLa cells. For
BMX-SH2, YES-SH2, and ZAP70-cSH2, mutations of ACP resi-
dues greatly reduced their PM localization, whereasmutations of
pY pocket residues had little effect on their PM recruitment
(Figure 1).
Molecular location of lipid-binding ACPs is highly variable
(Figures 2 and 3A). For instance, they are located on the oppo-
site side to their pY pockets for ZAP70-cSH2 and BMX-SH2,
Table 1. Lipid-Binding Properties of Human SH2 Domains
SH2 Domainsa Residue Number Kd (nM) for PM
b Lipid-Binding Residuesc PtdInsP Selectivityd
STAT6-SH2 517–632 20 ± 10
GRB7-SH2 411–532 70 ± 12 low selectivitye
FRK(PTK5)-SH2 109–213 80 ± 12
YES1-SH2 151–260 110 ± 12 R215, K216 PI45P2 > PIP3 > others
BLNK-SH2 326–456 120 ± 19 PIP3 > PI45P2 >> others
APS(SH2B2)-SH2 394–514 140 ± 11 low selectivity
NPLCg2-cSH2f 626–740 150 ± 13 R727, K728 PIP3 > PI45P2 >> others
BRK(PTK6)-SH2 71–175 150 ± 50 R131, R136 low selectivity
Tensin3-SH2 1,152–1,287 180 ± 23
SHIP1-SH2 1–106 190 ± 30 PIP3zPI45P2 >> others
Tensin2-SH2 1,120–1,250 200 ± 67
NSYK-cSH2f 148–264 210 ± 9 PIP3 > PI45P2 >> others
ITK-SH2 230–343 210 ± 372 low selectivity
HCK-SH2 157–267 220 ± 20
PI3K P85a-cSH2 604–718 220 ± 20
NPTPN6(SHP1)-nSH2g 1–99 240 ± 11 PIP3 > PI45P2>> others
FYN-SH2 141–250 250 ± 70 K182, R206, K207 low selectivity
ZAP70-cSH2f 164–259 340 ± 35 K176, K186, K206, K251 PIP3 > PI45P2 > others
NPLCg1-cSH2f 648–761 290 ± 16 R748, K749
GRB10-SH2 473–594 250 ± 50
Tensin1-SH2 1,443–1,577 300 ± 30 PIP3 >> others
NVAV3-SH2f 652–766 320 ± 49
LYN-SH2 121–230 320 ± 56
NPI3K p55g-cSH2f 338–452 330 ± 27
STAP1-SH2 159–276 350 ± 46
Tensin4-SH2 429–561 350 ± 35
BLK-SH2 116–224 360 ± 29
SPT6-cSH2e 1,424–1,515 420 ± 30 low selectivity
Yeast SPT6-cSH2f,h 1,351–1,440 430 ± 60
PI3K p85b-cSH2e 602–716 420 ± 350
SH2D2A-SH2 75–190 440 ± 35
NRASA1-nSH2g 161–276 440 ± 51 R188, R207 PIP3zPI45P2 > others
PI3K P85a-nSH2g 312–427 440 ± 80
NPI3K p55g-nSH2g 45–160 450 ± 31
SHC3-SH2 479–590 460 ± 15
PI3K p85b-nSH2g 310–425 460 ± 67
NPTPN6(SHP1)-cSH2f 90–214 480 ± 47
SOCS6-SH2 364–481 480 ± 24
SRC-SH2 144–253 450 ± 60
FGR(SRC2)-SH2 137–264 500 ± 41
GRB2-SH2 57–155 520 ± 15
BMX-SH2 276–397 550 ± 70 K313, K315 PI45P2 > PIP3 > others
SH3BP2-SH2 446–558 580 ± 95
BTK-SH2 273–382 640 ± 55 K311, K314 low selectivity
NCSK-SH2 71–191 670 ± 160
SH2D4A-SH2 327–443 670 ± 60
NPLCg1-nSH2g 530–659 710 ± 50
SH2B1-SH2 507–624 710 ± 350
(Continued on next page)
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Table 1. Continued
SH2 Domainsa Residue Number Kd (nM) for PM
b Lipid-Binding Residuesc PtdInsP Selectivityd
NCK1-SH2 262–376 730 ± 30
GRB14-SH2 418–540 730 ± 100 PIP3>> others
STAT3-SH2 580–670 670 ± 120
MATK-SH2 102–216 860 ± 90
CRK-SH2 1–124 960 ± 120
NVAV2-SH2 653–767 970 ± 190
SHF-SH2 303–419 970 ± 60
SHE-SH2 375–491 1000 ± 100
NPLCg2-nSH2g 512–637 1100 ± 110
NGRAP2-SH2 55–152 1300 ± 170
EAT2-SH2 1–106 1300 ± 280
SH2D3A-SH2 1–115 1500 ± 130
NGRAP-SH2 57–155 1600 ± 410
NCRKL-SH2 1–108 1600 ± 550
SH2D1A-SH2 1–107 1700 ± 260
NRASA1-cSH2 340–446 1800 ± 60
PTPN11(SHP2)-cSH2f 92–217 2000 ± 400
ABL1-SH2 120–222 2100 ± 400
PTPN11(SHP2)-nSH2g 1–102 2300 ± 570
SHC2-SH2 467–578 5400 ± 1800
SHC1-SH2 468–579 NMi
SYK-nSH2g 1–112 NM
ZAP70-nSH2g 1–107 NM
LNK-SH2 344–461 NM
SHD-SH2 220–336 NM
FES-SH2 440–550 NM
NTXK-SH2 141–266 NM
Supt6h-nSH2g 1,331–1,423 NM
aAll SH2 domains are expressed as C-terminal EGFP-fusion proteins unless specified otherwise (e.g., NPLCg2-cSH2 indicates the N-terminal EGFP-
fusion PLCg2-cSH2). For most SH2 domains, N-terminal and C-terminal EGFP tags have essentially the same effect, i.e., they significantly improved
the protein expression yield without affecting membrane-binding properties of SH2 domains. The C-terminal EGFP tag was selected over the N-ter-
minal one because the former tends to stabilize the SH2 domain better than the latter. For some SH2 domains, we employed the N-terminal EGFP tag
because the C-terminal EGFP tag interferes with their lipid binding.
bMean ± SD from triplicate equilibrium SPR measurements using PM-mimetic vesicles (POPC/POPE/POPS/PI/cholesterol/PtdIns(4,5)P2
[12:35:22:8:22:1]).
cDetermined by SPR analysis of mutants using PM-mimetic vesicles.
dDetermined by SPR analysis using seven different POPC/POPS/PtdInsP (77:20:3) vesicles. PIP3, phosphatidylinositol-3,4,5-trisphosphate; PI34P2,
phosphatidylinositol-3,4-bisphosphate; PI35P2, phosphatidylinositol-3,5-bisphosphate; PI45P2, phosphatidylinositol-4,5-bisphosphate; PI3P, phos-
phatidylinositol-3-monophosphate; PI4P, phosphatidylinositol-4-monophosphate; PI5P, phosphatidylinositol-5-monophosphate.
eThose SH2 domains that do not clearly distinguish among PI-bisphosphates and among PI-monophosphate.
fC-terminal SH2 domain of tSH2.
gN-terminal SH2 domain of tSH2.
hSPT6-cSH2 domain from S. cerevisiae.
iNot measurable with up to 10 mM proteins (i.e., Kd > 10 mM).whereas they are on the same surface with or about perpendic-
ular to the pY pockets for other SH2 domains, including Fyn-
SH2, Syk-cSH2, phospholipase Cg2 (PLCg2)-cSH2, YES1-
SH2, PLCg1-cSH2, RASA1-nSH2, PTK-SH2, and Btk-SH2.
Despite their positional variability, these sites do not overlap
with any known protein-binding sites, including the secondary
binding site to the pY motif (Pawson, 2004), a pY-independent10 Molecular Cell 62, 7–20, April 7, 2016protein-binding site reported for the PLCg-nSH2 (Bae et al.,
2009), and a second pY-binding site reported for PLCg1-cSH2
(Groesch et al., 2006). Indeed, molecular modeling of ZAP70-
cSH2, Fyn-SH2, and PTK6-SH2 suggests that they can bind a
lipid headgroup and a pY motif simultaneously and indepen-
dently (Figure 3B). This notion was supported by their identical
pY peptide binding with and without PM vesicles (Figure S3A)
YES1-SH2 WT YES1-SH2  
R185A 
YES1-SH2  
R215A/K216A 
Before PI45P2 depletion After PI45P2 depletion Before PIP3 enrichment After PIP3 enrichment 
B 
BMX-SH2 WT BMX-SH2  
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and unaltered vesicle binding in the presence of pY peptides
(Figure S3B). We also performed the modeling of ZAP70-cSH2
interacting with the PM-mimetic bilayer and the phosphorylated
T cell receptor (TCR) z chain (TCR-z), a key interaction partner of
ZAP70 in the activated TCR-signaling complex (Wang et al.,
2010; Figure S3C). The modeling suggests that ZAP70-cSH2
can simultaneously bind a PI45P2 molecule in the lipid bilayer
and a pY in its membrane-imbedded target protein. Further,
the presence of PM-mimetic vesicles did not affect the binding
of intact ZAP70 to the phosphorylated immunoreceptor tyro-
sine-based activation motif (ITAM) of TCR-z (Figure S3D). These
results indicate that ZAP70-cSH2 and other SH2 domains
can simultaneously bind a pY and lipids under physiological
conditions.
Lipid-binding ACPs are morphologically diverse. For example,
they form a pocket or groove for ZAP70-cSH2, BMX-SH2, Fyn-
SH2, Syk-cSH2, PLCg2-cSH2, and YES1-SH2, whereas they
are located on relatively flat surfaces for PTK6-SH2 and Btk-SH2
(Figure 2). This distinct morphology seems to affect the way they
interact with lipids. In general, SH2 domains with an ACP groove
show higher PtdInsP selectivity than those with a flat ACP. For
instance,ZAP70-cSH2hasselectivity forPIP3 (FigureS1), andmu-
tation of residues in their cationic grooves (i.e., K176 and K186)
abrogated the PIP3 selectivity (Figure 4A). Also, our computational
protein cavity analysis revealed a correlation between the ACP
groove dimension and the lipid headgroup specificity (Table S2).
The PIP3-selective ACP groove of ZAP70-cSH2 isz60% larger
than that of the PI45P2-selective ACP groove of BMX-SH2. All
these data support the notion that their ACP grooves are involved
in specific PtdInsP headgroup recognition. However, it should be
noted that ACP grooves of SH2 domains are considerably smaller
than that of the PIP3-specific BTK PHdomain (Figure 2; Table S2).
In conjunction with the different PtdInsP selectivity displayed by
SH2 and PH domains (Figure S1), these structural differences
suggest that SH2 and PH domains might recognize the PtdInsP
headgroup by different mechanisms.
To corroborate that ACP grooves are involved in specific
PtdInsP headgroup recognition, we monitored by solution
nuclear magnetic resonance (NMR) analysis the binding of
13C-labeled Fyn-SH2 to a soluble head group analog of PIP3,
D-myo-inositol-(1,3,4,5)-tetrakisphosphate (IP4). Upon binding
IP4, major chemical shift perturbations were detected primarily
on the residues constituting (i.e., K182 and R206) or surrounding
(e.g., Y185) the ACP groove; however, chemical shift perturba-
tions were insignificant for the pY pocket residues (Figure 3C).
Collectively, these results support the notion that the ACPFigure 1. Effect of PI45P2 Depletion and PIP3 Enrichment on the Subce
(A) PI45P2 depletion greatly reduced PM localization of PI45P2-selective BMX-S
WT whereas K313A/K315A showed dramatically reduced PM localization.
(B) PI45P2 depletion greatly inhibited PM localization of YES1-SH2 WT wherea
R215A/K216A showed dramatically reduced PM localization.
(C) Both PI45P2 depletion and PIP3 enrichment had only modest effects on PTK6-S
significantly reduced PM localization.
(D) PI45P2 depletion had aminor effect on PM localization of PIP3-selective ZAP70
R190A/R192A behaved similarly to WT. Between two lipid-binding LOF mutants,
some degree of enhanced PM localization. Both LOF mutants showed much red
(E) Control imaging of PI45P2 and PIP3 sensors demonstrates the robustness of ou
and 1 min after PI45P2 depletion and PIP3 enrichment. HeLa cells were used for
12 Molecular Cell 62, 7–20, April 7, 2016grooves serve as specific lipid-binding sites for those SH2 do-
mains with high lipid headgroup selectivity.
Role of Lipid Binding of ZAP70 cSH2 Domain in T Cell
Signaling
To investigate the physiological significance of lipid-binding
activities of SH2 domains, we selected ZAP70 for functional
studies. ZAP70 is a Syk family tyrosine kinase that plays a central
role in TCR signaling (Wang et al., 2010). It promotes the down-
streamT cell signaling by binding to double pYmotifs of ITAMs of
TCR-z via its tandem SH2 domains (tSH2) and subsequently
phosphorylating LAT and SLP-76. This leads to further down-
stream signaling activities, including phosphorylation of PLCg1
and ERK1/2 (Pollizzi and Powell, 2014).
Ourmodeling (Figure 3B) suggested that K176 and K186might
be involved in PIP3 recognition, whereas K206 and K251 might
non-specifically interact with all anionic PM lipids. Consistent
with this prediction, K176E/K186E lost PIP3 selectivity whereas
K206E/K251E did not (Figure 4A). Furthermore, PM localization
of ZAP70-cSH2 wild-type (WT) and K206E/K251E in HeLa cells
was enhanced in response to rapamycin-triggered PIP3 enrich-
ment, whereas that of K176E/K186E was not altered (Figure 1D).
Both mutants had 4- to 5-fold lower membrane affinity than WT
(Table S3), indicating that both specific PIP3 binding and non-
specific anionic lipid binding contribute to membrane binding
of ZAP70-cSH2.
To check if the lipid-binding site of ZAP70-cSH2 is active
in the context of the full-length protein, we measured the
vesicle binding of ZAP70-tSH2 and intact ZAP70. SPRmeasure-
ments showed that ZAP70-cSH2, ZAP70-tSH2, and the intact
ZAP70 have similar vesicle affinity (Figure S4A; Table S3). Also,
K176E/K186E and K206E/K251E mutations reduced the
vesicle-binding affinity of ZAP70-cSH2, ZAP70-tSH2, and the
intact ZAP70 to comparable degrees (Figure 4A; Figure S4C;
Table S3). These results, which are consistent with the crystal
structure of ZAP70-tSH2 (Hatada et al., 1995) in which the
ACP groove of ZAP70-cSH2 is fully exposed (Figure S4D),
show that the lipid-binding site of ZAP70-cSH2 is fully functional
in intact ZAP70 and that lipid-binding activity of ZAP70 lies
entirely within its cSH2 domain. Finally, neither mutation altered
binding of ZAP70-cSH2 to a pY-containing peptide (Figure S3E)
or binding of intact ZAP70 to the dual phosphorylated ITAM of
TCR-z (Figure S3F).
To elucidate how differently the two types of lipid binding
affect cellular activities of ZAP70, we compared the effects of
introducing WT and the two lipid-binding loss-of-function (LOF)llular Localization of mCherry-Tagged SH2 Domains
H2 WT, whereas PIP3 enrichment had little effect. R302A behaved similarly to
s PIP3 enrichment had little effect. R185A behaved similarly to WT whereas
H2WT. R85A/R105A behaved similarly toWTwhereas R131A/R136A showed
-cSH2WT, whereas PIP3 enrichment significantly enhanced its PM localization.
K176E/K186E did not respond to PIP3 enrichment while K206E/K251E showed
uced PM localization compared to WT.
r PI45P2 depletion and PIP3 enrichment systems. All images were taken before
all measurements. Scale bars represent 5 mm.
Figure 2. Surface Electrostatic Potential of Selected SH2 Domains
For each SH2 domain, the pY-binding pocket and the main alternate cationic patch (ACP) are indicated by red and green arrows, respectively. For ZAP70-cSH2
and BMX-SH2, structures are shown in two different orientations with 180 rotation because their main ACPs are located on the opposite side of the pY pockets.
Non-lipid-binding Syk-nSH2 and SHD-SH2 do not have ACPs. The PIP3-specific Btk-PH domain (PDB: 1b55) is shown for comparison. A green arrow indicates
its PIP3-binding pocket. All structures are shown in the same scale. In all cases, the minimal and maximal electrostatic potentials are 5kT/e (red) and +5kT/e
(blue), respectively.mutants of ZAP70 to ZAP70-deficient (P116) Jurkat cells on
TCR-signaling activities. Specifically, we monitored the time-
dependent tyrosine phosphorylation of ZAP70 and its down-
stream proteins, LAT, PLCg1, and ERK1/2, after stimulationwith an anti-CD3 antibody, OKT3. Tyr phosphorylation of these
proteins was completely suppressed in P116 cells; however,
when ZAP70 WT was reconstituted in P116 cells, all proteins
were rapidly phosphorylated after stimulation, which lastedMolecular Cell 62, 7–20, April 7, 2016 13
A 
B 
C Fyn-SH2  
ZAP70-cSH2 Fyn-SH2 PTK6-SH2 
PTK6-SH2 
R136 
R131 
ZAP70-cSH2 
K206 
K251 
K186 
K176 
K182 
R206 
Fyn-SH2 
K182 
R206 
Figure 3. Variable Location andMorphology of
Lipid-Binding Sites in SH2 Domains
(A) The structures of Fyn-SH2 and PTK6-SH2 are
shown in the same orientation with the pY-binding
pocket (red arrows) pointing upward. ZAP70-cSH2
is rotated 180 to show the face opposite to the
pY-binding pocket. Key cationic residues involved in
lipid binding are shown in space-filling representation
and labeled.
(B) Model structures of SH2-pY peptide-IP4 ternary
complexes. SH2 domains are shown in surface rep-
resentation and peptides (red arrows) and IP4 (green
arrows) are shown in stick representation. Notice that
there is no steric overlap between the peptide and IP4
for all SH2 domains.
(C) NMR chemical shift perturbations (CSPs) for
backbone amide signals of 13C-labeled Fyn-SH2 in
the presence of IP4. Residues with top 15%CSPs are
labeled in the left panel and highlighted in red in the
right panel. The residues whose NMR signals are
missing after IP4 titration are colored in green. Notice
that major CSPs are focused near K182 and R206 for
Fyn-SH2.for 10–15 min (Figure 4C). Interestingly, two LOF mutants of
ZAP70 showed distinctively different temporal phenotypes.
K206E/K251E was much less effective than WT throughout the
entire activation period, whereas the PIP3-specific mutant,
K176E/K186E, was almost as active as WT at an earlier stage
but became much less effective at later stages (>5 min). These
results suggest that PIP3-ZAP70 interaction is important not for
initiating the TCR-signaling activity of ZAP70 but for sustaining
it. We also measured the cellular calcium flux and interleukin-2
release after OKT3 stimulation. P116 cells again showed no
calcium flux and interleukin-2 release after OKT3 stimulation,
but stable expression of ZAP70WT dramatically enhanced these
activities (Figures 4D and 4E). In both assays, K176E/K186E and
K206E/K251E were much less active than WT, although the
former was slightly more active than the latter.
We also prepared a gain-of-function (GOF) mutant for ZAP70,
D184K, which had higher membrane affinity than WT (Table S3)
but retained PIP3 specificity (Figure 4B) and pY-binding affinity
(Figure S3E). Consistent with increased membrane affinity,
D184K was considerably more active than the WT protein in
both calcium flux and ERK1/2 phosphorylation assay (Figure S5).14 Molecular Cell 62, 7–20, April 7, 2016As a control, we also measured the
signaling activity of a pY binding-deficient
mutant of ZAP70 (R190A/R192A) and it
showed no detectable activity in all assays
(Figures 4C–4E).
To better understand the mechanisms
underlying the distinct cellular phenotypes
of the ZAP70 mutants, we monitored dy-
namic interaction of ZAP70WT andmutants
with TCR-z by two-color single-molecule
tracking (Koyama-Honda et al., 2005; Sheng
et al., 2012). We first transfected EGFP-
ZAP70 and the SNAP-tetramethylrhod-
amine (TMR)-labeled TCR-z into P116 cellsand tracked these molecules simultaneously. Although ZAP70
is a cytosolic protein, it showed a high degree of PM localization
before stimulation as previously reported (Huby et al., 1997).
However, it showeda lowdegree of colocalizationwith TCR-zun-
til cells were stimulatedwithOKT3 (Figure 5A;MoviesS1 andS2).
Detailed kinetic analysis of ZAP70-TCR-z colocalization
showed how differently OKT3 stimulation modulates the dy-
namic colocalization of TCR-z with ZAP70 WT and various
mutants. For ZAP70 WT, the OKT3 stimulation for 2 min caused
z2-fold increase in ZAP70-TCR-z colocalization in terms of
half-life of colocalization, which lasted for >10 min before it
was reduced to the basal level (Figure 5C; Figure S6A). Under
the same conditions, K206E/K251E displayed no significant
increase in colocalization with TCR-z throughout the entire acti-
vation period (Figures 5Band5C;Movies S3 andS4; Figure S6B).
Interestingly, K176E/K186E showed a significant degree of
colocalization with TCR-z at 2–5 min just as WT did, but the co-
localization rapidly decreased thereafter (Figure 5C; Figure S6C).
Pre-treatment of P116 cells with a phosphoinositide 3-kinase
(PI3K) inhibitor, LY294002, exerted essentially the same effect
as the K176E/K186E mutation (Figure 5C; Figure S6D). The
CE
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D
Figure 4. Membrane-Binding Properties and Cellular Activities of ZAP70 WT and Mutants
(A) PIP3 dependence of ZAP70-cSH2 and its LOF mutants. ZAP70-cSH2 shows higher affinity when PI45P2 in the PM-mimetic vesicles (PM) is replaced by PIP3
(PM*) (blue curves). K176E/K186E (red curves) lost PIP3 selectivity whereas K206E/K251E (green curves) retained it, suggesting that K176 and K186 are directly
involved in PIP3 headgroup recognition while K206 and K251 are directly involved in non-specific binding to anionic membranes.
(B) PIP3 dependence of a ZAP70-cSH2 GOF mutant. D184K shows enhanced membrane affinity while retaining PIP3 selectivity (orange). PM, PM-mimetic
vesicles; PM*, PM – PI45P2 + PIP3.
(C) Time course shows Tyr phosphorylation of TCR-signaling proteins in P116 cells expressing EGFP-tagged ZAP70 WT, lipid-binding LOF mutants, and a
pY-binding site mutant after OKT3 stimulation.
(D) Calcium mobilization in P116 cells expressing EGFP-tagged ZAP70 WT and mutants after OKT3 stimulation. Each circle represents a single cell. ***p < 0.001
(Student’s t test).
(E) IL-2 release from P116 cells expressing EGFP-tagged ZAP70 WT and mutants before and after OKT3 stimulation is shown.
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Figure 5. Single-Molecule Tracking of
ZAP70 and TCR-z in the TCR Complex
(A and B) Representative images of EGFP-ZAP70
WT (A) or K206E/K251E (B) and SNAP-TMR-
labeled TCR-z in a P116 cell before and after OKT3
stimulation are shown. Green, red, and yellow
lines are trajectories of ZAP70, TCR-z, and colo-
calized molecules, respectively. Arrows indicate
the starting points of tracking. See also Movies S1,
S2, S3, and S4. The scale bar represents 1 mm.
(C) Time courses of the half-life of colocalization
for EGFP-ZAP70 WT and lipid-binding mutants
with SNAP-TMR TCR-z are shown.
(D) Time courses of the half-life of colocalization for
EGFP-ZAP70WT and a pY site mutant with SNAP-
TMR TCR-z. The half-life of colocalization was
calculated from the dissociation rate constant. The
same size of PM surface was analyzed for each
histogram. Error bars indicate SD (n = 50–100).GOF mutant (D184K) showed considerably enhanced PM
recruitment even before OKT3 stimulation and a higher degree
of colocalization with TCR-z than WT over the entire OKT3
stimulation period (Figure 5C; Figure S6E). In contrast, the pY
binding-deficient mutant, R190A/R192A, consistently showed
much lower colocalization with TCR-z than WT (Figure 5D).
Collectively, these results suggest that initial PM lipid (e.g.,
PI45P2) binding of ZAP70-cSH2 is essential for facilitating the
interaction of ZAP70 with TCR-z and that its subsequent binding
to PIP3 produced by PI3K activation is important for their sus-
tained interaction. This notion is also consistent with the unique
temporal effects of the PIP3-specific K176E/K186E mutation on
the TCR-signaling activity of ZAP70 (Figure 4C).
To assess the physiological relevance of the lipid-mediated
control of ZAP70-TCR-z interaction observed in single-molecule
imaging, we also performed co-immunoprecipitation of ZAP70
WT and mutants with TCR-z. As expected, OKT stimulation
dramatically enhanced the co-immunoprecipitation of ZAP70
WT with TCR-z (Figure S6F). Under the same conditions, how-
ever, OKT stimulation caused z50% less co-immunoprecipi-
tation between ZAP70-K206E/K251E and TCR-z, which was
comparable to the degree of co-immunoprecipitation between
ZAP70-R190A/R192A and TCR-z. Since both mutants still
possess an intact nSH2, they are expected to show some degree
of interaction with TCR-z under the conditions of co-immunopre-
cipitation involving overexpressed proteins. It should be noted,
however, that even under these conditions compromised lipid
binding by the K206E/K251E mutation caused essentially the
same negative effect on ZAP70-TCR-z interaction as loss of
pY binding by the R190A/R192A mutation.
Role of Non-specific Lipid Binding of SH2 Domains in
Cell-Signaling Pathways
PTK6 is a non-myristoylated, non-receptor tyrosine kinase that is
aberrantly expressed in several types of human cancer (Brauer16 Molecular Cell 62, 7–20, April 7, 2016and Tyner, 2009). To check if non-specific
lipid binding of SH2 domains is also
important for the cellular function and
regulation of their host proteins, wemeasured the effect of altering the lipid-binding activity of
PTK6-SH2 on the cellular activity of PTK6. It was reported
recently that in a prostate cancer cell line (PC3) the pool of
endogenous activated PTK6, marked by auto-phosphorylation
at Y342, was localized at the PM and promoted the phosphory-
lation and activation of ERK5 and Akt (Zheng et al., 2012).
Consistent with the report, activation of HEK293 cells overex-
pressing PTK6 WT led to PTK6 Y342 phosphorylation (Fig-
ure S7B), PM recruitment (Figure S7E), and phosphorylation of
ERK5 (Figure S7C) and Akt1 (Figure S7D). However, an LOF
mutant (R131A/R136A) with z5-fold lower PM affinity than WT
(Figure S7A) showed a dramatically reduced degree of Y342 au-
tophosphorylation (Figure S7B) and PM localization (Figure S7E),
and it was much less effective than WT in phosphorylating ERK5
and Akt1 (Figures S7C and S7D). As a control, we also measured
the effects of the pY-binding site mutation (R85A/R105A) and it
was much less active than WT in all assays. These results lend
further credence to the notion that lipid-binding activity of SH2
domains, whether it is through specific headgroup recognition
or non-specific binding, is important for cell signaling.
DISCUSSION
The present study demonstrates that most SH2 domains bind
PM lipids with high affinity via ACPs. Many ACP-containing
SH2 domains also bind PtdInsPs as specifically as PH domains.
All SH2 domains characterized herein have lipid-binding ACPs
that are topologically and functionally separate from the pY
pockets, allowing them to bind the pY peptide and lipids inde-
pendently. This salient feature enables them to serve as dual-
specificity lipid- and protein-binding modules whose protein
interactionmay be directly and specifically modulated by various
lipids.
Although the location of lipid-binding ACPs is highly variable,
they are expected to be surface exposed and fully functional in
the full-length proteins, as evidenced by the comparable mem-
brane affinity of ZAP70-cSH2, ZAP70-tSH2, and the intact
ZAP70 (Table S3). This would allow constitutive PM recruitment
of SH2 domain-containing proteins (see Figure 1), priming them
for agonist-induced binding to pY-containing proteins. Lipids
can recruit and compartmentalize a wide range of effector pro-
teins to confined membrane locations (Cho and Stahelin, 2005;
Lemmon, 2008) and also allosterically regulate their structures
and orientation (Cho, 2006). These activities should directly
and specifically facilitate binding of SH2 domains to pY-contain-
ing protein partners. Consequently, relative location of the ACP
and the pY pocket would dictate how PM-associated SH2
domain proteins interact with their interaction partners. Highly
variable location of lipid-binding ACPs in SH2 domains would
thus allow for flexible lipid-mediated regulatory mechanisms
for pY-signaling pathways.
Variable morphology of lipid-binding ACPs also enables SH2
domains to bind lipids by different mechanisms. Groove-forming
ACPs can specifically recognize lipid headgroups, whereas flat
ACPs tend to non-specifically interact with anionic lipids. This
correlation between the ACP morphology and the lipid-binding
mechanism is corroborated by our PtdInsP selectivity measure-
ments and computational cavity analysis. Our SPR analysis
shows thatz60% of tested SH2 domains have definite PtdInsP
specificity. This in turn indicates that a significant number of SH2
domains non-specifically bind PM lipids. Physiological signifi-
cance of specific PtdInsP binding by lipid-binding domains has
been well documented (Di Paolo and De Camilli, 2006; Lemmon,
2008), but the importance of non-specific lipid binding in cellular
function and regulation has only recently started to be appreci-
ated (Cho, 2006; Heo et al., 2006; McLaughlin and Murray,
2005; Winters et al., 2005; Wu et al., 2007). Our cell studies on
ZAP70 and PTK6 show that both specific headgroup recognition
and non-specific lipid binding by SH2 domains are physiologi-
cally important. It is thus expected that lipids will play important
roles in modulating cellular activities of most, if not all, proteins
with high-affinity lipid-binding SH2 domains, whether they bind
lipids specifically or non-specifically. Functional studies on
ZAP70 and PTK6 with different cellular functions also suggest
that the lipid-SH2 interactionmay be a common critical regulato-
ry step for most pY-signaling pathways involving lipid-binding
SH2 domains.
Functional and single-molecule studies of ZAP70 demonstrate
how multiple lipids work in concert to achieve exquisite spatio-
temporal control over SH2 domain-mediated protein-protein in-
teractions and cell-signaling activities. ZAP70-cSH2 has PIP3
selectivity but it can also tightly bind PI45P2-containing PM-
mimetic vesicles (Figure S1; Table 1). As a result, ZAP70-cSH2
(Figure 1) and intact ZAP70 (Figure 5) exhibit a high degree of
PM recruitment before TCR stimulation. Judging from the
inability of ZAP70 K206E/K251, which has much reduced affinity
for the PM but intact affinity for pY, to effectively interact with
TCR-z in response to OKT3 stimulation, this constitutive PM
binding seems to be essential for facilitating binding of ZAP70
to target proteins in the activated TCR-signaling complex. The
subsequent PI3K-mediated conversion of PI45P2 into PIP3,
which would specifically bind to the ACP groove of ZAP70-
cSH2 and thus enhance the PM binding of ZAP70, appears tobe crucial for elongated interaction of ZAP70 with TCR-z in the
activated TCR complex. Differential temporal regulation of
ZAP70 activities by these two distinct types of lipid binding epit-
omizes how a concerted action of multiple lipids enables exqui-
site spatiotemporal coordination of protein-protein interactions
and cell-signaling activities. Given that other proteins involved
in B and T cell signaling also have high PM affinity and PIP3
selectivity (Table 1), PM lipids and PIP3 might spatiotemporally
modulate and coordinate the actions of multiple SH2 domain
proteins during T or B cell activation, leading to high-fidelity pY
signaling.
Strong lipid-binding activity of two primordial SH2 domains
(Liu and Nash, 2012), SPT6-cSH2 and STAT6-SH2, suggests
that this activity was adopted at least as early as their pY-binding
activity in evolution (Table 1). This point is further supported by
the finding that human and Saccharomyces cerevisiae SPT6-
cSH2 domains have essentially identical affinity for PM-mimetic
vesicles. Since both SPT6 and STAT are nuclear proteins
involved in gene regulation, the lipid-binding activity of SH2 do-
mains must have been acquired even before the PM became the
central stage for pY signaling. Normally, functionally important
residues are highly conserved through evolution. As described
above, however, variability of lipid-binding residues among
different SH2 domains is evolutionarily more advantageous
than conservation because the former allows SH2 domains to
adopt different modes of lipid and pY binding that ideally
suit their cellular functions. It should be stressed, however, that
for each SH2 domain, the conservation of lipid-binding resi-
dues among species is extremely high. For instance, multiple
sequence alignment of ZAP70-cSH2 and Fyn-SH2 orthologs
shows that essential lipid-binding residues are absolutely or
highly conserved through evolution.
Since many SH2 domain proteins are implicated in human dis-
eases, SH2 domains have been targeted for drug development
(Kraskouskaya et al., 2013); however, extensive efforts to modu-
late their pY binding have met with limited success, due to struc-
tural similarity and ligand promiscuity of the pY-binding pockets.
Our study showing the ligand specificity and structural diversity
of lipid-binding sites of SH2 domains, in conjunction with the
finding that many disease-causing mutations of SH2 domain
proteins are found in the lipid-binding sites of SH2 domains
(Table 2), could point a way toward a new alternate strategy for
controlling pY-signaling activities with improved specificity and
potency.
Lastly, it should be noted that our results on lipid-binding
sites of SH2 domains are at odds with previous studies sug-
gesting that some SH2 domains bind lipids in their pY pockets
(Hong et al., 2009; Rameh et al., 1995; Tokonzaba et al., 2006).
Although the origin of this discrepancy is not fully understood,
one can speculate that some SH2 domains without ACPs may
be able to bind a lipid(s) in their pY pockets given that the
shape and electrostatic properties of pY pockets vary signifi-
cantly among SH2 domains. For such SH2 domains, lipid and
protein binding could be mutually exclusive or interfere with
each other. Obviously, further studies on other SH2 domain-
containing proteins are necessary to fully elucidate different
regulatory mechanisms for lipid-mediated protein interactions
in pY signaling.Molecular Cell 62, 7–20, April 7, 2016 17
Table 2. Disease-Causing Mutations in the Lipid-Binding Sites of
SH2 Domains
SH2 Domains Lipid-Binding Residuesa Mutationsb
BRK(PTK6)-SH2 R131, R136 COSMIC: R131P (1)
and R131L (1)
YES1-SH2 R215, K216 COSMIC: R215M (1)
BLNK-SH2 K380, R399, R411,
K412
ClinVar: R399N
(malignant melanoma)
and COSMIC: R399Q (1)
PLCg2-cSH2 K687, R727, K728 COSMIC: R727Q (2)
FYN-SH2 K182, R206, K207 COSMIC: R206C (5)
BMX-SH2 K313, K315 COSMIC: K313Q (1)
Obtained from three public-domain databases as follows: Human Gene
Mutation Database (HGMD), ClinVar, and Catalogue of Somatic Muta-
tions in Cancer (COSMIC). Mutations in the professional version of
HGMD are not included.
aThose identified from our mutational and NMR analyses.
bThe number in parentheses is the number of reported occurrence(s) in
the COSMIC database.EXPERIMENTAL PROCEDURES
Full protocols can be found in the Supplemental Experimental Procedures.
Protein Expression and Purification
All EGFP-tagged SH2 domains and full-length proteins were expressed as
His6-tagged proteins in E. coli BL21 (DE3) pLysS (Novagen) and purified using
the Ni-NTA-Agarose resin (QIAGEN).
Lipid Vesicle Preparation and SPR Analysis
PM-mimetic vesicles were prepared by mixing POPC, POPE, POPS, choles-
terol, PI, and PI45P2 in a molar ratio of 12:35:22:22:8:1. All SPRmeasurements
were performed at 23C using the lipid-coated L1 chip in the BIACORE X or
T100 system as described previously (Stahelin and Cho, 2001). Tris-HCl
(20 mM [pH 7.4]) containing 0.16 M NaCl was used as the running buffer,
while PM-mimetic vesicles and POPC vesicles were coated on the active
surface and the control surface, respectively. Flow rate was 5 ml/min and
20–30 ml/min for equilibrium and kinetic measurements, respectively. Relative
response (on the scale of 0–1) was calculated by dividing resonance unit (RU)
values by the maximal RU obtained for a particular protein under a given con-
dition, and it was used for most figures to minimize data variation caused by
experimental factors, most notably different instrumental parameters of three
separate SPR instruments used for measurements.
Stable Cell Line Preparation
A Jurkat cell line derivative, P116 (CRL-2676), was from ATCC and cultured
in RPMI 1640 containing 5% fetal bovine serum (FBS). GFP-ZAP70 WT and
mutants were stably expressed in P116 by retroviral gene transduction. A
retroviral construct, pLEGFP-N1-hZap70, was cloned by PCR and point muta-
tions were introduced by site-directed mutagenesis. Retrovirus preparation
and transduction were performed as previously described (Kim et al., 2013).
Rapamycin-Inducible PI45P2 Depletion and PIP3 Enrichment
The PI45P2 depletion was performed in HeLa cells according to a reported
procedure (Inoue et al., 2005; Varnai et al., 2006) using Lyn-based PM-
anchored FKBP12-rapamycin-binding (FRB) domain of mTOR (Lyn-FRB)
and the FK506-binding protein-12-yeast inositol polyphosphate 5-phospha-
tase domain fusion protein (FKBP-Inp). PM translocation of mCherry-ZAP70-
cSH2 WT and mutants was monitored in the presence of 2.5 mM rapamycin
analog, A/C Heterodimerizer (Clontech Laboratories). The PIP3 enhancement
system consisted of Lyn-FRB and YFP-tagged FKBP with an inter-SH2
domain of p85b (Inoue and Meyer, 2008). Robustness of these systems was18 Molecular Cell 62, 7–20, April 7, 2016tested using microinjected PI45P2 (Yoon et al., 2011) and PIP3 (Liu et al.,
2014) sensors.
Single-Cell Calcium Imaging
Cells were loaded with 2 mg/ml Fura-2 AM (Life Technologies) in phenol
red-free DMEM containing 0.5% FBS for 30 min at 37C, washed, and plated
to a poly-L-lysine-coated culture plate for imaging. The changes in the fluores-
cence emission of calcium-bound and unbound form of Fura-2 were captured
and the ratio of individual cells was analyzed using MetaFluor (Molecular
Devices) and Prism (GraphPad) software.
Tyrosine Phosphorylation Assay
Cells expressing WT or mutant GFP-ZAP70 were stimulated with OKT3
(3 mg/ml) at 37C for the indicated time. Cells were then lysed with the ice-
cold radioimmunoprecipitation assay buffer supplemented with a mixture of
protease and protein phosphatase inhibitors. Proteins were separated by
SDS-PAGE, transferred to a nitrocellulose membrane, and probed with anti-
bodies against pLAT (Y191), pPLCg1 (Y783), pERK1/2 (T202/Y204), pZAP70
(Y493), and b-actin. The chemiluminescence was detected with ImageQuant
LAS 4000 (GE Healthcare).
IL-2 ELISA
Cells were added to a 96-well plate (2 3 106 cells per well) coated with OKT3
and anti-CD28 antibodies and incubated for 24 hr. The levels of IL-2 in culture
supernatants were measured by sandwich ELISA (eBioscience).
Single-Molecule Tracking by Total Internal Reflection Fluorescence
Microscopy
Single-molecule imaging was performed in P116 cells using a custom-built to-
tal internal reflection fluorescencemicroscope as described previously (Sheng
et al., 2012). P116 cells stably expressing EGFP-ZAP70 WT (or mutants) were
transiently transfected with SNAP-TCR-z, which was subsequently labeled
with SNAP-Cell tetramethylrhodamine (TMR)-Star (New England Biolabs).
Labeled cells were washed, attached to a poly-L-lysine-coated glass plate,
stimulated with 10 mg/ml OKT3, and ZAP70 and TCR-zmolecules were simul-
taneously tracked. PIP3 depletion was achieved by pre-treating the cells with
50 mM LY294002 for 1 hr before OKT3 stimulation. All particle tracking, data
analysis, and image processing were carried out with in-house programs writ-
ten inMATLAB. Colocalization analysis of twomolecules was performed with a
fixed-threshold criterion (i.e., <400 nm) for colocalization (Koyama-Honda
et al., 2005). The same size of PM surface was analyzed for each item of
data. The percentage of TCR-z molecules spending a given colocalzation
time (>0.2 s) with ZAP70 on the PM was calculated from the total number of
TCR-z molecules and displayed as a histogram. Data were fit into a single
exponential decay equation (i.e., p = Po e
kt) to determine the dissociation
rate constant (k) values by non-linear least-squares analysis, and the half-life
values of colocalization were calculated as ln2/k. Images (50–100) were
analyzed for each data point.
Structural Modeling, Electrostatic Analysis, and Docking of SH2
Domains
Themodels for SH2 domains were created withModeler 9.9 (Sali and Blundell,
1993). DelPhi (Rocchia et al., 2001) was used for assigning electrostatic poten-
tials to the atoms of the structures using CHARMM force field (MacKerell et al.,
1998). The calculated potentials were loaded into GRASP2 (Petrey and Honig,
2003) for subsequent visualization. Docking of the lipids to the structure of SH2
domains was performed with the DOCK program of the package DOCK 6, us-
ing the Amber score program, which allows both the ligand and the active site
of the receptor to be flexible (Graves et al., 2008).
NMR Data Acquisition and Processing
The 1H and 13C heteronuclear single-quantum correlation (HSQC) experiments
were recorded at 600 and 800 MHz on Bruker Avance spectrometers at 20C.
The samples contained 0.1 mM 13C-labeled Fyn-SH2 in 25 mM potassium
phosphate, 2 mM dithiothreitol, and 5% deuterium oxide (pH 6.0). The chem-
ical shift perturbations, upon the addition of 1 mM IP4, were calculated from
1H
and 13C chemical shifts using a weighted averaging scheme.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, three tables, and four movies and can be found with this article
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